Menopausal hormone therapy and risk of venous thromboembolism: the story so far

• Main Authors: Mohsen M.A. Abdelhafez, Karim A. M. Ahmed, Nashwa A.M. Ahmed, Mohd H. Ismail, Mohd Nazri Mohd Daud, Aya M. Eldiastey, Mohd Fariz Amri, Mohammad Saffree Jeffree, Fairrul Masnah @ Kadir, Dg Marshitah Pg Baharuddin, Mohammad Firdaus Bolong @ Mohd Darwis, Mohd Firdaus Hayati, Nornazirah Azizan, Doreen Sumpat, Syed Sharizman Syed Abdul Rahim, Win W. Than, Mohd Y. Ibrahim, Zhen Z. Lo, May, Zaw Soe
• Format: Article
• Language: English; English
• Published: African Journal of Reproductive Health/Women's Health and Action Research Centre (WHARC) 2024
• Subjects: R5-920 Medicine (General); RG159-208 Functional and systemic disorders. Endocrine gynecology
• Online Access: https://eprints.ums.edu.my/id/eprint/41068/3/ABSTRACT.pdf; https://eprints.ums.edu.my/id/eprint/41068/2/FULL%20TEXT.pdf; https://eprints.ums.edu.my/id/eprint/41068/

Menopausal hormone therapy (MHT) is known to increase the risk of venous thromboembolism (VTE), which includes deep vein thrombosis, pulmonary embolism, and less frequently cerebral vein thrombosis, but the absolute risk for a given patient is very low. After starting MHT, the risk of VTE seems to b...